利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.028 秒)

    Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
    1.
    发明申请
    Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis 审中-公开
    新型Curcuminoid因子VIIA构建体作为肿瘤生长抑制因子和血管发生

    公开(公告)号：US20090011991A1

    公开(公告)日：2009-01-08

    申请号：US12035995

    申请日：2008-02-22

    申请人： Mamoru Shoji ,  James Synder ,  Dennis Liotta ,  Aiming Sun

    发明人： Mamoru Shoji ,  James Synder ,  Dennis Liotta ,  Aiming Sun

    IPC分类号： A61K38/36 ,  A61P35/00

    CPC分类号： C12Y304/21021 ,  A61K47/6425 ,  C07D213/63 ,  C07D213/64 ,  C12N9/6437

    摘要： The fluorinated curcuminoid (3,5-bis-(2-fluorobenzylidene)-piperidin-4-one-acetate is about ten times more effective at arresting the growth of tumor cells than cisplatin. Conjugates for delivering a cytotoxic compound, such as a curcuminoid, specifically to cancer cells and to the vascular endothelial cells that nourish solid tumors, and methods of making and using thereof are described herein. The conjugate contains a cytotoxic compound bound to a protein such as in factor VIIa that retains high affinity for the surface protein tissue factor. The cytotoxic compound is bound to the protein via a linker and a hydrolyzable bond. Upon complexation, the resulting heterodimer is endocytosed and the drug is subsequently liberated inside the target cell via proteolytic cleavage.

    摘要翻译： 氟化姜黄素（3,5-双 - （2-氟亚苄基） - 哌啶-4-酮乙酸酯在阻止肿瘤细胞生长方面比顺铂高约十倍。用于递送细胞毒性化合物如姜黄素的缀合物 具体涉及癌细胞和滋养实体瘤的血管内皮细胞，本文描述了制备和使用它们的方法，该缀合物含有与蛋白质结合的细胞毒性化合物，例如对表达蛋白保持高亲和力的因子VIIa 细胞毒性化合物通过接头和可水解键与蛋白质结合，络合时，得到的异源二聚体被内吞，然后通过蛋白水解切割将药物释放到靶细胞内。

    Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
    2.
    发明申请
    Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis 审中-公开
    新型姜黄素因子VIIa构建成肿瘤生长和血管生成抑制因子

    公开(公告)号：US20060229239A9

    公开(公告)日：2006-10-12

    申请号：US10383898

    申请日：2003-03-07

    申请人： Mamoru Shoji ,  James Snyder ,  Dennis Liotta ,  Aiming Sun

    发明人： Mamoru Shoji ,  James Snyder ,  Dennis Liotta ,  Aiming Sun

    IPC分类号： A61K38/17

    CPC分类号： C12Y304/21021 ,  A61K47/64 ,  A61K47/6425 ,  C07D213/63 ,  C12N9/6437

    摘要： The fluorinated curcuminoid (3,5-bis-(2-fluorobenzylidene)-piperidin-4-one-acetate is about ten times more effective at arresting the growth of tumor cells than cisplatin. The present invention provides methods to deliver a cytotoxic compound, such as a curcuminoid, specifically to cancer cells and to the vascular endothelial cells that nourish solid tumors. The method involves tethering the drug to a protein such as in factor VIIa that retains high affinity for the surface protein tissue factor. Upon complexation, the resulting heterodimer is endocytosed and the drug is subsequently liberated inside the target cell via proteolytic cleavage. The present invention further provides for the synthesis of novel curcuminoid-tether-linker-factor VIIa compositions and for methods of delivery of effective doses of the novel compositions to target tumor or endothelial cells in a patient

    摘要翻译： 氟化姜黄素（3,5-双 - （2-氟亚苄基） - 哌啶-4-酮乙酸酯在阻止肿瘤细胞生长方面比顺铂高约十倍。本发明提供递送细胞毒性化合物的方法， 例如姜黄素，特别是癌细胞和滋养实体瘤的血管内皮细胞，该方法涉及将药物系在蛋白质上，例如对表面蛋白组织因子保持高亲和力的因子VIIa，在复合后，产生 异二聚体被内吞，并且药物随后通过蛋白水解切割在靶细胞内释放。本发明还提供了新型姜黄素 - 连接子 - 连接因子VIIa组合物的合成和用于将有效剂量的新组合物递送至靶 肿瘤或内皮细胞

    PRODRUGS OF CURCUMIN ANALOGS
    3.
    发明申请
    PRODRUGS OF CURCUMIN ANALOGS 审中-公开
    曲霉素类似物的研究

    公开(公告)号：US20070270464A1

    公开(公告)日：2007-11-22

    申请号：US11678156

    申请日：2007-02-23

    申请人： Dennis Liotta ,  James Snyder ,  Mamoru Shoji ,  Yang Lu ,  Aiming Sun

    发明人： Dennis Liotta ,  James Snyder ,  Mamoru Shoji ,  Yang Lu ,  Aiming Sun

    IPC分类号： A61K38/10 ,  A61K31/4433 ,  A61K31/4436 ,  A61K31/4545 ,  A61P3/10 ,  C07D211/44 ,  C07D211/82 ,  C07D401/12 ,  C07D405/06 ,  C07D409/06 ,  A61K38/08 ,  A61K38/06 ,  A61K38/05

    CPC分类号： C07D211/74

    摘要： The invention provides sulfur-linked and nitrogen-linked peptidic conjugates of curcumin analogs that can provide increased water solubility and photostability as compared to the corresponding unmodified curcumin analogs without sacrificing therapeutic efficacy. The conjugates, which are believed to act as prodrugs, can be used therapeutically in the same manner as the unmodified curcumin analogs, such as in the treatment or prevention of cancer, diabetes, or inflammatory diseases. One conjugate comprises 3,5-Bis-(2-fluorobenzylidene)-piperidin-4-one, or a salt thereof, covalently attached through a sulfur linkage to a thiol-containing peptide such as glutathione.

    摘要翻译： 本发明提供与相应的未修饰的姜黄素类似物相比，可以提供增加的水溶性和光稳定性的姜黄素类似物的硫连接和氮连接的肽共轭物，而不牺牲治疗功效。 被认为用作前药的缀合物可以以与未修饰的姜黄素类似物相同的方式治疗地使用，例如在治疗或预防癌症，糖尿病或炎症性疾病中。 一个缀合物包含通过硫键共价连接到含硫醇的肽如谷胱甘肽的3,5-双 - （2-氟亚苄基） - 哌啶-4-酮或其盐。

    Cytotoxic compound-protein conjugates as suppressors of tumor growth and angiogenesis
    4.
    发明申请
    Cytotoxic compound-protein conjugates as suppressors of tumor growth and angiogenesis 审中-公开
    细胞毒性复合物 - 蛋​​白质缀合物作为肿瘤生长和血管发生的抑制剂

    公开(公告)号：US20050069551A1

    公开(公告)日：2005-03-31

    申请号：US10900490

    申请日：2004-07-28

    申请人： Mamoru Shoji ,  James Snyder ,  Dennis Liotta ,  Aiming Sun

    发明人： Mamoru Shoji ,  James Snyder ,  Dennis Liotta ,  Aiming Sun

    IPC分类号： A61K47/48 ,  C07D213/63 ,  C12N9/64 ,  A61K39/395 ,  C07K16/46

    CPC分类号： C12N9/6437 ,  A61K47/64 ,  A61K47/642 ,  A61K47/6849 ,  C07D213/63 ,  C12Y304/21021

    摘要： Compositions and methods are provided for delivering cytotoxic compounds, such as natural curcumoids and synthetic curcumin analogs, specifically to cancer cells and to blood vessels that nourish solid tumors. The compositions include a cytotoxic drug tethered to a protein, such as factor VIIa, which can bind with high affinity to a receptor, such as tissue factor, expressed on the surface of cancer cells and vascular endothelial cells within the tumor microenvironment. Upon binding, the drug-protein-receptor complex is endocytosed and the drug is subsequently liberated inside the target cell via proteolytic cleavage. The compositions and methods may increase the efficacy of the cytotoxic agets and decrease their side effects by delivering the agents to specific target cells, such as cancer cells, vascular endothelial cells in a tumor, and metastatic foci anywhere in the body, providing the target cells express surface bound tissue factor. Additionally, methods of synthesis of cytotoxic compound-protein conjugates are provided, for example, curcuminoid-tether-linker-factor VIIa composition, as well as pharmaceutically acceptable compositions and methods for delivering a therapeutically-effective amount of a cytotoxic compound-protein conjugate together with one or more pharmaceutically acceptable carriers (additives) and/or diluents to an animal or human patient.

    摘要翻译： 提供组合物和方法用于递送细胞毒性化合物，例如天然的姜黄素和合成的姜黄素类似物，特别是癌细胞和滋养实体瘤的血管。 组合物包括与诸如因子VIIa结合的蛋白质的细胞毒性药物，其可以高度亲和力结合到在肿瘤微环境中在癌细胞表面和血管内皮细胞表面上的受体，例如组织因子。 结合后，药物 - 蛋​​白 - 受体复合物被内吞，并且药物随后通过蛋白水解切割在靶细胞内释放。 组合物和方法可以通过将药物递送到特定靶细胞，例如肿瘤中的癌细胞，血管内皮细胞和体内任何地方的转移灶，来增加细胞毒性作用的功效并降低其副作用，提供靶细胞 表达结合组织因子。 此外，提供了合成细胞毒性化合物 - 蛋​​白质缀合物的方法，例如，姜黄素 - 链 - 连接体 - 因子VIIa组合物，以及用于将治疗有效量的细胞毒性化合物 - 蛋​​白质缀合物一起递送的药学上可接受的组合物和方法 与动物或人类患者的一种或多种药学上可接受的载体（添加剂）和/或稀释剂。